Xoma | XOMA - Ebitda





Ebitda Veränderung Datum
AbbVie USD 5.37B 1.85B 2025-12
Agenus USD -10.11M 19.02M 2025-03
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Ardelyx USD -29.77M 35.79M 2026-03
aTyr Pharma USD -54K 25.9M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Celldex Therapeutics USD -83.58M 2.76M 2026-03
Curis USD -12.3M 231K 2023-09
Eli Lilly USD 12.14B 4.26B 2025-12
Incyte USD 367.97M 46.53M 2026-03
MacroGenics USD -30.2M 52.15M 2026-03
Novartis USD 5.3B 530M 2026-03
Novartis USD 5.41B 431M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Prothena USD 25.98M 65.51M 2026-03
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Xoma USD 2.52M 7.98M 2024-06